The weekend was not quiet. Markets open Tuesday.

Russia–Ukraine War ESCALATING

Russia launched its largest single attack on Kyiv since the full-scale invasion began Sunday — 600 drones and 90 missiles, including a third Oreshnik hypersonic ballistic strike, hitting 40 locations across the capital and killing at least four. The Oreshnik, which can carry nuclear warheads, struck Bila Tserkva, 50 miles south of the city. Zelensky called the strike "criminal and insane" and demanded Western consequences; EU foreign policy chief Kaja Kallas called the Oreshnik use "reckless nuclear brinkmanship." Peace talks remain nominally scheduled, but this attack came as Russia's stated response to Ukrainian drone strikes on Russian territory.

US–Iran Ceasefire DE-ESCALATING

The US and Iran agreed to a framework Monday extending the existing ceasefire 60 days while both sides work toward a final settlement — with the Strait of Hormuz to be demined and reopened during that window, a senior US administration official confirmed. Key unresolved issues remain: Iran's 408.6 kilograms of 60%-enriched uranium, sanctions relief timing, and Tehran's demand for formal recognition of Iranian maritime authority over the strait. Brent crude was near $100 on Friday; futures markets are pricing a deal as more likely than not, but the framework is not a final deal.

Global Bond Rout ESCALATING

The 30-year Treasury closed Friday at 5.09%, near its highest level since 2007, with US markets shut for Memorial Day and reopening Tuesday. The One Big Beautiful Bill — which the CBO scores as adding $3.4 trillion to deficits over ten years — now moves to the Senate, where at least four Republican senators have signaled opposition to the Medicaid cuts. Moody's downgraded US sovereign debt to Aa1 the week prior. The Senate debate will determine whether the fiscal path that's been driving the bond selloff gets wider or narrower.

Warsh Fed Transition HOLDING

Kevin Warsh was sworn in at the White House on May 22 — the first Fed chair swearing-in held there since Alan Greenspan in 1987. He inherits a committee holding rates at 3.50%–3.75%, four dissents at its last meeting, and a bond market pricing zero cuts for the rest of 2026. Trump is publicly demanding cuts. At least three FOMC members have signaled rate hikes are under active consideration. Warsh has made no public statements on policy direction since taking office. His first press conference arrives June 17 — 23 days away.

Ebola — DRC & East Africa NEW

As of May 24, the Bundibugyo Ebola outbreak has confirmed cases in three DRC provinces — Ituri, North Kivu, and South Kivu — plus five cases in Uganda's capital Kampala. Total suspected cases have crossed 968, with at least 216 deaths. The WHO declared a Public Health Emergency of International Concern on May 17; Africa CDC declared a continental security emergency May 18. No approved vaccine or treatment exists for the Bundibugyo strain. CDC and DHS announced enhanced US entry screening on May 18. One American has been evacuated to a German isolation ward.

AI IPO Wave ESCALATING

SpaceX's S-1 is public, targeting a $1.75–$2 trillion Nasdaq debut June 12. OpenAI filed its confidential S-1 the same week, targeting Labor Day through Thanksgiving at an $850 billion valuation. Starship V3 completed its first successful test flight May 22, strengthening the SpaceX IPO narrative hours before the roadshow window opens June 4. Both companies are drawing from the same institutional capital pool — into a bond market where the 30-year yield remains near a 19-year high.

China Rare Earth Deadline HOLDING

The Wave 2 suspension of China's rare earth export controls expires November 10, 2026 — 169 days out. The Beijing summit produced acknowledgment of US concerns but no licenses, no verification mechanism, and no structural change to the control framework. Chinese customs data shows yttrium exports to the US remain below 35% of pre-control volumes. The EU-US trade deal ratified this week includes no provisions addressing rare earth dependencies. The clock is running.

Russia fired a nuclear-capable missile at Kyiv. Again.

CONFIDENCE: HIGH

What

Russia launched 600 drones and 90 missiles at Kyiv on Sunday — the largest single attack on the Ukrainian capital since the full-scale invasion began. For the third time in the war, Russia fired an Oreshnik hypersonic ballistic missile, striking Bila Tserkva, a city of 200,000 people roughly 50 miles south of the capital. Ukrainian air defenses intercepted most of the drones and over half the missiles. At least four people were killed and more than 60 wounded. Damage was recorded in 40 locations across every district of Kyiv, including residential buildings, schools, and the Cabinet of Ministers building.

So What

The Oreshnik is not a conventional weapon deployed for its warhead yield. It is a political instrument. Russia first fired it against Ukraine in November 2024; the second use came in January 2026. Each deployment is a public demonstration of a weapon that cannot currently be intercepted, capable of carrying nuclear payloads, and explicitly placed where Western intelligence can observe it. The pace is accelerating — three uses in six months. That pattern has a purpose. Moscow is running the weapon at a tempo designed to normalize it: the first launch was alarming, the second was concerning, the third barely held the front page past 24 hours. Normalization is the point. Russia detonated the last Oreshnik alongside the largest nuclear exercise in its post-Soviet history, which concluded days ago. These are not separate decisions. The timing of Sunday's attack — as a US-Iran ceasefire framework was being finalized and Western attention was fixed on Hormuz — suggests an awareness of bandwidth. Washington cannot fully concentrate on two nuclear-adjacent escalations at once. That is not coincidence; it is the strategy.

Now What

Watch for the NATO response framing this week — specifically whether member states describe Sunday's strike as an escalation requiring policy review or as an unfortunate but familiar event. The language gap between those two framings is where Russia's calculus lives. Any NATO emergency session request before Thursday signals the alliance is treating Sunday differently. Silence signals the opposite.

Warsh is in the chair. The fight starts June 17.

CONFIDENCE: HIGH

What

Kevin Warsh was sworn in as the 17th Federal Reserve chair at the White House on May 22 — confirmed 54-45, the narrowest Fed confirmation in the modern era. He inherits a committee holding rates at 3.50%–3.75%, a CPI running at 3.8% year-over-year, a PPI that printed 6.0% annually in April, and a bond market pricing zero cuts at any remaining 2026 FOMC meeting. Trump has demanded cuts publicly and repeatedly. At least three FOMC members have called rate hikes a live contingency in recent public remarks. Warsh has said nothing on policy direction since taking office. His first press conference is June 17.

So What

The Warsh appointment was sold as a mechanism for rate cuts — the political rationale was explicit. The economic reality he inherited makes cuts structurally difficult. Producer prices running at 6.0% annually, with consumer inflation still near 4%, give the committee no room to ease without publicly abandoning the 2% mandate. Warsh's own prior writing and public record suggest he is more hawkish on inflation than Powell, not less. That creates a scenario where the president and the chair he appointed are immediately in conflict — not eventually, but in three weeks. Markets are priced for continuity. The S&P 500 is near all-time highs. The June 17 press conference is the first moment the market will hear from the new chair, and it may not like what it hears. The 30-year yield at 5.09% is already pricing something the equity market has not accepted. That gap between what bonds and stocks are saying about the fiscal and inflation path is not stable.

Now What

Watch for any Warsh public statement before June 17 — a speech, a congressional appearance, an on-the-record comment to a reporter. The absence of any communication through June 16 would itself be informative: it means he is saving every signal for the press conference, which typically causes larger market moves when expectations are unanchored. The July 2 jobs report and the July 14 CPI print will define whether the rate hike contingency becomes a live debate at the July meeting.

Ebola is in five cities. There is no vaccine for this strain.

CONFIDENCE: MODERATE

What

As of May 24, the Bundibugyo Ebola outbreak has confirmed cases in three DRC provinces — Ituri, North Kivu, and South Kivu — plus five cases in Uganda's capital Kampala. The WHO declared a Public Health Emergency of International Concern on May 17. Africa CDC declared a continental security emergency the following day. Total suspected cases have reached 968 with at least 216 deaths, and WHO officials have stated the actual number likely exceeds reported figures. One American has been evacuated to a German isolation unit. CDC and DHS announced enhanced US border screening on May 18. This is the 17th recorded Ebola outbreak in DRC — and the first to reach Uganda's capital city.

So What

The Bundibugyo strain matters for one reason that has been largely absent from coverage: the approved Ebola vaccines — rVSV-ZEBOV and Ad26.ZEBOV/MVA-BN-Filo — were developed and tested against the Zaire ebolavirus strain. They have no confirmed efficacy against Bundibugyo. The same applies to the approved treatment, Inmazeb. This outbreak is not a version of the 2018-2020 Kivu epidemic, where response teams had working tools. Response teams here are operating without a licensed vaccine or specific antiviral. The outbreak is expanding across three provinces in an active conflict zone with limited road access, dense cross-border trade, and the DRC's historically constrained public health infrastructure. Kampala is a regional hub with direct air links to Nairobi, Addis Ababa, Dubai, and Doha. The WHO risk assessment for international spread is classified as "high" — the same designation it carried in the 2018-2020 outbreak before it killed over 2,000 people.

Now What

Watch for any confirmed case outside East or Central Africa — a European or Gulf state imported case would trigger a new phase of international response and accelerate travel restriction decisions. WHO's IHR Emergency Committee meets again this week; their risk assessment language will tell you how close the international public health machinery is to declaring this a pandemic-category concern rather than a regional one.

The EU-US trade deal has a trapdoor. It opens December 31.

The EU Parliament ratified the Turnberry trade deal this week — the agreement Trump and von der Leyen signed at his Scottish golf resort in July 2025, capping most EU tariffs at 15%. The coverage focused on the ratification as a diplomatic win. The mechanism nobody is reading is buried in the final text: the European Commission is empowered to suspend all tariff preferences on steel and aluminum if the US continues to apply a rate above 15% on EU steel and aluminum derivatives past December 31, 2026. US tariffs on those categories remain at 50% today. Trump has made no commitment to reduce them. The entire agreement can collapse on a single commodity sector that Washington has shown no interest in conceding.

Steel and aluminum are not a footnote. They are the sector Trump has treated as structurally non-negotiable since 2018. The EU side knows this; four MEPs voted against ratification on the grounds that the safeguard was not strong enough to mean anything. The regulation includes a sunset clause under which the entire framework ceases to operate at the end of 2029 unless renewed — which means the US administration in 2028 could let the deal expire passively, without a formal withdrawal. The combination of the December trigger and the 2029 sunset creates a trade architecture that looks permanent from a headline distance and is actually two clocks running simultaneously.

This is buried because the ratification story played as resolution after months of tension. The December 31 trigger gets one sentence in most reporting; the 2029 sunset gets none. Trade editors focused on the passage; the exit mechanism is in Annex II of the Council regulation text. The companies most exposed — European steelmakers, German auto parts suppliers — have not sounded a public alarm because the December deadline is still seven months out.

SOURCE: EU Council Regulation 2026/[final text], May 20, 2026; Euronews, "EU Parliament approves implementation of US tariff deal," May 20, 2026; CNBC, "EU clears major hurdle to finalize US trade pact," May 20, 2026.

Markets are closed today. That is worth noting, because what happened over the weekend cannot be traded until Tuesday — and it was not a quiet weekend. Russia fired a nuclear-capable hypersonic missile at Kyiv for the third time in six months. A new Ebola strain with no approved vaccine has reached a regional capital with international air connections. The US and Iran sketched a 60-day ceasefire framework that leaves every core dispute unresolved. And the new Federal Reserve chair begins his tenure three weeks from a press conference where investors have no anchor for what he will say.

The EU-US trade deal ratification looked like stabilization. The bond market's continued signal — 30-year Treasuries at 5.09% on a holiday-shortened Friday — looked like routine. Neither is. The bond market is pricing the One Big Beautiful Bill, which now moves to a Senate with four wavering Republicans and a deficit score of $3.4 trillion over ten years. The trade deal has an expiration mechanism tied to a tariff category Washington has refused to touch for eight years.

Tuesday's open will be the first tradable moment for all of it. The gap between equity pricing and everything else is not new — but it is wider this morning than it was Friday, and Friday it was already wide.

Read time: ~4 min

The Recon Report  ·  Daily Intelligence Briefing